Sort
30,917 grants matching “tumor microenvironment”
The Role of Lumican in the cornea
$405,900Shukti Chakravarti · Johns Hopkins University · R01 · FY2010 · EY
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$405,874Elana Fertig · Johns Hopkins University · U01 · FY2020 · CA
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
$405,794Simone Krebs · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$405,707Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2014 · CA
Microglial Kynurenine Pathway and Selective Neuronal Vulnerability
$405,692Paul J Muchowski · J. David Gladstone Institutes · P01 · FY2010 · AG
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.
$405,676Jun-Li Luo · Scripps Research Institute, The · R01 · FY2015 · CA
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$405,651Ankur Singh · Georgia Institute Of Technology · R01 · FY2024 · CA
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics
$405,558Xiaoqing Yu · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2023 · CA
Proton Relaxation and Exchange Contrast in MRI
$405,554John C Gore · Vanderbilt University Medical Center · R01 · FY2018 · EB
Proton Relaxation and Exchange Contrast in MRI
$405,554John C Gore · Vanderbilt University Medical Center · R01 · FY2019 · EB
Development of a Therapeutic Monoclonal Antibody Against EGFL6, a Mediator of Tumor Growth and Metastasis
$405,552Thaddeus David Allen · Tradewind Bioscience, Inc. · R41 · FY2021 · CA
Data Analysis Unit
$405,511Kai Tan · Children'S Hosp Of Philadelphia · U2C · FY2022 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma
$405,493Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2024 · CA
High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics
$405,491Peter John Espenshade · Johns Hopkins University · R01 · FY2022 · CA
Targeting metastatic tumors with engineered cellular therapies
$405,478Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · CA
Functional Activation of Low Affinity TILs
$405,441Jill E Slansky · University Of Colorado Denver · R01 · FY2023 · CA
Cell lineage as an indicator of immune response in neuroblastoma
$405,378Rani E George · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Cell lineage as an indicator of immune response in neuroblastoma
$405,378Rani E George · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Optimizing Targeted Breast Cancer Therapy by Mathematical Modeling and Experimental Studies
$405,375William Thomas Baumann · Virginia Polytechnic Inst And St Univ · R01 · FY2017 · CA
Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients
$405,316Fred Kinyuy Tabung · Ohio State University · R21 · FY2024 · CA
Transfer of microRNA regulators from glioblastoma to brain microenvironment
$405,296Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2017 · CA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$405,225Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
CLINICAL THERAPY TRIALS
$405,218Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA